About this trial
This study will be carried out to compare between the effect of 4%Tulsi gel and 1%Chlorohexidine gel as locally administered agents in the treatment of advanced periodontitis. Clinical parameters measurements, microbiological and radiographic assessment will be performed at base line, one month and 3 months after the intervention.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients included in this study will be having advancedI Periodontitis
Aging from 30 to 50 years old
Free from any local or systemic risk factors that may affect the results of the study.
Disqualifiers
Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing.
Pregnant woman and lactating mothers.
Patients with previous periodontal treatment including scaling and root planning and periodontal surgery in the last 3 and 6 months, respectively.
Trial design
Parallel
Treatments tested in this trial
Tulsi gel
DrugAfter scaling and root debridement, 4% of Tulsi gel will be injected in to the sulcus until it over flooded, at base line, then after one month.
Chlorhexidine gel
DrugAfter scaling and root debridement, 1% of Chlorhexidine gel will be injected in to the sulcus until it over flooded, at base line, then after one month.
Treatment groups
Trial outcomes
Primary outcomes
Clinical parameters
Improvement of the clinical attachment loss in millimeters.
Clinical parameters
Improvement of gingival index.
Clinical parameters
Improvement of probing depth in millimeters.
Secondary outcomes
Microbiological assessment
Counting microbial colony of Porphyromonas gingivalis
Microbiological assessment
Counting microbial colony of Fusobacterium nucleatum
Microbiological assessment
Counting microbial colony of Tannerella forsythia
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: